Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113717071A reveals a green visible light catalyzed method for acetamide synthesis, offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN105418525B offers safer catalytic synthesis for benzotriazin-one intermediates reducing cost and improving supply chain reliability for pharma.
Patent CN104557551B reveals solvent-free phase transfer catalysis for benzyl salicylate. Achieve high purity and yield with reduced environmental impact for scalable supply.
Patent CN108047230B reveals a novel acridine salt photocatalytic route for Ponatinib. Discover cost-effective, high-purity API manufacturing solutions.
Patent CN110183498A reveals air-stable ferrocene ligands enabling cost-effective manganese-catalyzed asymmetric hydrogenation for pharmaceutical intermediate manufacturing.
Novel phosphorylation method for Vidarabine Phosphate reduces toxicity and cost. Reliable supply chain partner for antiviral drug intermediates.
Patent CN111233829A details a mild asymmetric reduction method for high-purity nicotine, offering significant cost reduction in fine chemical manufacturing and scalable supply chain solutions.
Patent CN106279075B reveals iron-catalyzed HMF conversion to DMF. Achieve cost reduction in renewable chemical intermediates manufacturing with scalable heterogeneous catalysis.
Patent CN115611713A reveals a mild blue light method for fluorene derivatives, offering cost-effective and scalable production for optoelectronic material supply chains.
Patent CN109666011A reveals high-concentration oxidation method for FDCA. Delivers high purity and cost reduction in pharmaceutical intermediate manufacturing with scalable processes.
Patent CN109554406A enables efficient keto acid production. Reduces coenzyme cost and improves supply chain reliability for pharma intermediates.
Novel BN-NP synthesis via patent CN114853794B offers high yield and purity for electronic chemical manufacturing supply chains.
Novel catalytic method ensures high yield and purity for porphyrin compounds. Reduces equipment corrosion and simplifies supply chain for pharmaceutical intermediates.
Patent CN102309984B reveals a novel cinchona-derived catalyst enabling high-efficiency asymmetric synthesis with simplified supply chains and reduced manufacturing costs.
Novel plant-derived synthesis route for Ursodeoxycholic Acid ensures high purity and supply continuity. Ideal for pharmaceutical intermediates manufacturing.
Novel patent CN105399672A offers safer Huperzine A synthesis. Reduces cost and improves supply chain reliability for Alzheimer's drug manufacturers globally.
Patent CN111205185A introduces a green visible light method for β-trifluoromethyl alcohol using manganese catalysts, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN104774889B details a novel fructosyltransferase method for sucrose-6-acetate, offering high yield and purity for reliable supply chain integration.
Patent CN115974792B introduces a novel carbon bond catalyst with high yield and mild conditions, ensuring supply chain reliability and cost efficiency.
Novel tridentate nitrogen ligand for asymmetric Michael addition. High yield, low catalyst loading. Reliable supply for pharma intermediates.